Feeling sick to your stomach (nausea) Throwing up (vomiting) Infusion reactions Diarrhea Infections Increased cough Headache Feeling tired Shortness of breath Rash Low white and red blood cell count Muscle pain Some patients receiving HERCEPTIN for metastatic stomach cancer had the following side effec...
[13]Wagner A, Grabsch H, Mauer M, et al. EORTC-1203 GITC "INNOVATION": Integration of trastuzumab (T), with or without pertuzumab (P), into perioperative chemotherapy of HER-2 positive stomach cancer: Overall survival results. 2025 ASCO GI. LBA331. [14]Shitara K, Wainberg Z, Tabernero...
[10]Li J,Qin S,Xu J,et al.Randomized,Double-Blind,Placebo-Controlled Phase III Trial of Apatinib in Patients With Chemotherapy-Refractory Advanced or Metastatic Adenocarcinoma of the Stomach or Gastroesophageal Junction.J Clin Oncol.2016...
SurgeryCornerstonesCombined Modality TherapyMetastatic Malignant Neoplasm to the Peritoneuminterdisciplinary approachLymph NodesReceptor, ErbB-2Cancer of StomachPrimeThe rates of gastric cancer, which is the third leading cause of cancer-related deaths worldwide, vary depending on geographic location. Margin-...
[4]Shen L, Chen P, Lu J, et al. Trastuzumab deruxtecan (T-DXd) in Chinese patients (pts) with previously treated HER2-positive locally advanced/metastatic gastric cancer (GC) or gastroesophageal junction adenocarcinoma (GEJA): Primary efficacy and safety from the phase II single-arm DESTINY...
39. Shen L, Gong J, Niu Z, et al. The preliminary efficacy and safety of KN026 combined with KN046 treatment in HER2-positive locally advanced unresectable or metastatic gastric/gastroesophageal junction cancer without prior systemic treatment in ...
11、Therapeutic strategies for esophagogastric junction cancer 12、Esophageal Cancer: Introduction 13、梅奥诊所 癌症专栏 14、Dedicated Multidetector CT of the Stomach: Spectrum of Diseases
9. NCCN Guidelines for Patients. Stomach Cancer,2021. 10. Mitani S, Kawakami H. Emerging Targeted Therapies for HER2 Positive Gastric Cancer That Can Overcome Trastuzumab Resistance[J]. Cancers, 2020, 12(2): 400. 11. Janjigian Y Y, Maron S B, Chatila W K, et al. First-line pembrolizu...
Extra-gain of HER2-positive cases through HER2 reassessment in primary and metastatic sites in advancedgastric cancer with initially HER2-negative primary tumours: results of GASTric cancer HER2 reassessmentstudy 1 (GASTHER1)[J]. Eur J Cancer, 2016,53:42–50. DOI: 10.1016/j.ejca.2015.09.018 ...
172P-Trastuzumab deruxtecan (T-DXd) in Chinese patients (pts) with previously treated HER2-positive locally advanced/metastatic gastric cancer (GC) or gastroesophageal junction adenocarcinoma (GEJA): Primary efficacy and safety from the phase II single-arm DESTINY-Gastric06 (DG06) trial ...